1. Home
  2. KKR^D vs VRXAW Comparison

KKR^D vs VRXAW Comparison

Compare KKR^D & VRXAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KKR^D

KKR & Co. Inc. 6.25% Series D Mandatory Convertible Preferred Stock

N/A

Current Price

$0.00

Market Cap

0.0

Sector

N/A

ML Signal

N/A

Logo Veraxa Biotech AG Warrants

VRXAW

Veraxa Biotech AG Warrants

N/A

Current Price

$0.07

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KKR^D
VRXAW
Founded
N/A
N/A
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
KKR^D
VRXAW
Price
N/A
$0.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
7.7K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
$0.07
52 Week High
N/A
$0.23

Technical Indicators

Market Signals
Indicator
KKR^D
VRXAW
Relative Strength Index (RSI) N/A 38.20
Support Level N/A N/A
Resistance Level N/A $0.10
Average True Range (ATR) 0.00 0.01
MACD 0.00 0.00
Stochastic Oscillator 0.00 4.48

Price Performance

Historical Comparison
KKR^D
VRXAW

About VRXAW Veraxa Biotech AG Warrants

Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.

Share on Social Networks: